The emerging UK copyright scene is seeing a considerable shift. While classic psychedelics like LSD and psilocybin remain prevalent , a new wave of interest is focused on emerging compounds. N,N-Dimethyltryptamine, often connected to profound mystical experiences, is receiving significant attention, alongside the newly discovered cannabinoid CBG ,